BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37461831)

  • 1. Renal Neuroendocrine Tumor: A Case Report with Evaluation of Grading Criteria and Relationship with Carbonic Anhydrase 9 Immunoreactivity.
    Monroe HL; Patadji Santiago S; Williams HJ; El Naili R
    Int J Surg Pathol; 2024 May; 32(3):570-577. PubMed ID: 37461831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell neuroendocrine tumor of the pancreas in von Hippel-Lindau disease: a case report and literature review.
    Woo CG; Choi SY; Kwak JJ; Chin S; Kim HK
    Neuro Endocrinol Lett; 2017 May; 38(2):83-86. PubMed ID: 28650600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of carbonic anhydrase 9, glucose transporter 1, and paired box 8 in von Hippel-Lindau disease-related lesions.
    Chatzopoulos K; Aubry MC; Gupta S
    Hum Pathol; 2022 May; 123():93-101. PubMed ID: 35196526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.
    Montani M; Heinimann K; von Teichman A; Rudolph T; Perren A; Moch H
    Am J Surg Pathol; 2010 Jun; 34(6):806-15. PubMed ID: 20431476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic renal cell carcinoma versus pancreatic neuroendocrine tumor in von Hippel-Lindau disease: treatment with interleukin-2.
    Williams C; Walther M
    ScientificWorldJournal; 2005 Jan; 5():9-10. PubMed ID: 15674444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease.
    Hoang MP; Hruban RH; Albores-Saavedra J
    Am J Surg Pathol; 2001 May; 25(5):602-9. PubMed ID: 11342771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease].
    Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F
    Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
    Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
    Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease.
    Gucer H; Szentgyorgyi E; Ezzat S; Asa SL; Mete O
    Virchows Arch; 2013 Oct; 463(4):593-7. PubMed ID: 23913169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
    Corleto VD; Cotesta D; Petramala L; Panzuto F; Pagnini C; Masoni L; Verrienti A; Delle Fave G; Filetti S; Letizia C
    JOP; 2009 Sep; 10(5):562-5. PubMed ID: 19734639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent updates on grading and classification of neuroendocrine tumors.
    Kim JY; Hong SM; Ro JY
    Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.
    Williamson SR; Zhang S; Eble JN; Grignon DJ; Martignoni G; Brunelli M; Wang M; Gobbo S; Baldridge LA; Cheng L
    Am J Surg Pathol; 2013 Aug; 37(8):1131-9. PubMed ID: 23648463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic mixed serous neuroendocrine neoplasm with clear cells leading to diagnosis of von Hippel Lindau disease.
    Kakkar A; Sharma MC; Yadav R; Panwar R; Mathur SR; Iyer VK; Sahni P
    Pathol Res Pract; 2016 Aug; 212(8):747-50. PubMed ID: 27161305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.
    Lubensky IA; Pack S; Ault D; Vortmeyer AO; Libutti SK; Choyke PL; Walther MM; Linehan WM; Zhuang Z
    Am J Pathol; 1998 Jul; 153(1):223-31. PubMed ID: 9665483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of magnetic resonance imaging findings in pancreatic and other abdominal manifestations of Von Hippel-Lindau disease in a series of 23 patients: a pictorial review.
    Graziani R; Mautone S; Vigo M; Manfredi R; Opocher G; Falconi M
    JOP; 2014 Jan; 15(1):1-18. PubMed ID: 24413778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
    Kim JY; Hong SM
    Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors in renal cell carcinoma].
    Wen JJ; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):850-3. PubMed ID: 24507112
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancreatic metastasis from renal cell carcinoma causing massive gastrointestinal bleeding in von Hippel-Lindau disease.
    Sugiyama M; Katsura M; Yamamoto K; Nouchi W; Abe N; Hatano N; Atomi Y
    Hepatogastroenterology; 1999; 46(26):1199-201. PubMed ID: 10370691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.
    Rohan SM; Xiao Y; Liang Y; Dudas ME; Al-Ahmadie HA; Fine SW; Gopalan A; Reuter VE; Rosenblum MK; Russo P; Tickoo SK
    Mod Pathol; 2011 Sep; 24(9):1207-20. PubMed ID: 21602815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.